medigraphic.com
Revista Cubana de Anestesiología y Reanimación

2020, Number 1

Revista Cubana de Anestesiología y Reanimación 2020; 19 (1)

Anesthetic management of neuroendocrine tumors regarding a case of paraganglioma

Redondo GZA, Segura LN

Language: Spanish
References: 11
Page: 1-14
PDF size: 294.32 Kb.


ABSTRACT

Introduction: Paraganglioma is a rare neuroendocrine tumor that emerging from the extra-adrenal autonomic paraganglia and it may occur in several parts of the body. Paraganglioma is also named extra-adrenals pheochromocytomas. Roughly 90 % of these tumors are benign and can be excised through surgery whereas 10 % of them are malignant and cause distant metastasis. Paragangliomas are closely linked to pheochromocytomas because they cannot be differentiated at cell level and often share the same clinical manifestations such as hypertension, episodic headache, sweating and tachycardia. The diagnosis of these tumors is important because of risk of becoming malignant, the implications of other related neoplasias and the possibility of making genetic studies to detect other cases in the same family.
Objective: To expose about epidemiology, clinical manifestations, diagnostic tests and perioperative management of these tumors by a presentation of a clinical case.
Case Report: Female 56 years old, clinical history of 2 years of uncontrolled hypertension, diabetes mellitus, who presented with headache, palpitations and feeling of warm. She was diagnosed with a pararrenal mass suspected of paraganglioma associated with catecholamine hypersecretion, confirmed by histopathology.
Conclusions: The treatment of these tumors requires a more complete surgical resection possible since the prognosis depends. Surgical management of pheochromocytoma needs special perioperative requirements. The anesthesiologist must observe this surgery, establish the risks of the phase pre-intra and postoperative.


REFERENCES

  1. Pinto A, Barletta JA. Adrenal Tumors in Adults. Surg Pathol Clin. 2015[acceso: 6/06/2019];8(4):725-49. Disponible en : https://www.ncbi.nlm.nih.gov/pubmed/26612224

  2. 2.Kiernan C, Solórzano C. Pheochromocytoma and Paraganglioma. Surg Oncol Clin N Am. 2016[acceso: 6/06/2019];25(1):119-38. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/26610778

  3. National Comprehensive Cancer Network. NCCN Guidelines Version 1. USA: NCCN, 2014 Neuroendocrine Tumors. 2013, MS23-M25.

  4. Martín Curto LM, Coronado Poggio M, Coya Viña J. PET/PET-CT en el diagnóstico oncológico. En: Hernán Cortéz-Funez. Tratado de Oncología. Barcelona: Publicaciones Permanyer; 2009:481-96.

  5. Acosta Ramón V, Estíbaliz López de Goicoecha-Saiz Maite, Pariente Rodrigo Emilio. A propósito de un caso de paraganglioma. Revista Cubana de Endocrinología. 2016 [acceso: 6/06/2019];27(2):149-155. Disponible en: http://revendocrinologia.sld.cu/index.php/endocrinologia/issue/view/3

  6. Herbert C, Sippel RS, Pacak K. The North American Neuroendocrine Tumor Society Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors: Pheochromocytoma, Paraganglioma, and Medullary Thyroid Cancer. Pancreas. 2010[acceso: 6/06/2019];39(6):775-83. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/20664475

  7. Cheng Y, Lin H, Rui Y, Junfeng Y. Paraganglioma of the renal pelvis: a case report and review of literature. Tumory. 2017[acceso: 6/06/2019];103(suppl 1):S47-49. Disponible en: https://www.researchgate.net/publication/319061899_Paraganglioma_of_the_renal_pelvis_a_case_report_and_review_of_literature

  8. Schwartz JJ, Akhtar S, Rosebaum SH. Función endocrina. En: Paul Barash- Anestesia clínica 8va ed. Wolters Kluwer; 2017. p. 1349-56.

  9. Fleisher LA, Mythen M. Implicaciones anestésicas de las enfermedades concurrentes. En: Ronald D. Miller. Anestesia. 8va ed. (en español). Madrid: Elsevier; 2016. p. 1170-73.

  10. Rubio Marín AC, Orjuela AD, Rascovsky M, Rosselli D. Hipertensión secundaria a paraganglioma: presentación de un caso y revisión de la literatura. Iatreia. 2016[acceso: 6/06/2019];29(2):206-217. Disponible en: http://www.scielo.org.co/scielo.php?pid=S0121-07932016000200009&script=sci_abstract&tlng=es

  11. Lord MS, Augoustides JGT. Perioperative management of pheochromocytoma: Focus on magnesium, clevidipine, and vasopressin. J Cardiothorac Vasc Anesth. 2012[acceso: 6/06/2019];26(3):526-31. Disponible en : https://www.researchgate.net/publication/221857840_Perioperative_Management_of_Pheochromocytoma_Focus_on_Magnesium_Clevidipine_and_Vasopressin




2020     |     www.medigraphic.com